| Obesity and thyroid cancer MA Marcello, LL Cunha, FA Batista, LS Ward Endocrine-related cancer 21 (5), T255-T271, 2014 | 121 | 2014 |
| Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases PD Kruithof, S Lunev, SPA Lozano, F de Assis Batista, ZM Al-dahmani, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (6), 165716, 2020 | 49 | 2020 |
| Identification and validation of novel drug targets for the treatment of Plasmodium falciparum malaria: new insights S Lunev, FA Batista, SS Bosch, C Wrenger, MR Groves InTech, 2016 | 29 | 2016 |
| Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro S Lunev, S Butzloff, AR Romero, M Linzke, FA Batista, KA Meissner, ... PloS one 13 (4), e0195011, 2018 | 25 | 2018 |
| Serum interleukin measurement may help identify thyroid cancer patients with active disease MB Martins, MA Marcello, F de Assis Batista, KC Peres, M Meneghetti, ... Clinical biochemistry 52, 1-7, 2018 | 21 | 2018 |
| A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosa JP Wibowo, FA Batista, N van Oosterwijk, MR Groves, FJ Dekker, ... International Journal of Biological Macromolecules, 2020 | 20 | 2020 |
| Drug Target Validation Methods in Malaria-Protein Interference Assay (PIA) as a Tool for Highly Specific Drug Target Validation K A Meissner, S Lunev, YZ Wang, M Linzke, F de Assis Batista, ... Current drug targets 18 (9), 1069-1085, 2017 | 18 | 2017 |
| Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum S Lunev, SS Bosch, FA Batista, C Wrenger, MR Groves Acta Crystallographica Section F: Structural Biology Communications 72 (7 …, 2016 | 18 | 2016 |
| Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2 SS Bosch, S Lunev, FA Batista, M Linzke, T Kronenberger, ASS Domling, ... ACS infectious diseases 6 (5), 986-999, 2020 | 12 | 2020 |
| Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature PA Boonstra, JA Gietema, AJH Suurmeijer, MR Groves, F de Assis Batista Oncotarget 8 (65), 109836, 2017 | 12 | 2017 |
| Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression FA Batista, LS Ward, MA Marcello, MB Martins, KC Peres, C Torricelli, ... Journal of endocrinological investigation 39 (4), 423-429, 2016 | 11 | 2016 |
| Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase S Lunev, SS Bosch, FA Batista, C Wang, J Li, M Linzke, P Kruithof, ... Biochemical and biophysical research communications 497 (3), 835-842, 2018 | 8 | 2018 |
| Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes ZM Al-Dahmani, X Li, LM Wiggenhauser, H Ott, PD Kruithof, S Lunev, ... Scientific Reports 12 (1), 1-7, 2022 | 7 | 2022 |
| New directions in antimalarial target validation FA Batista, B Gyau, JF Vilacha, SS Bosch, S Lunev, C Wrenger, ... Expert Opinion on Drug Discovery 15 (2), 189-202, 2020 | 7 | 2020 |
| CD8+ TIL Recruitment May Revert the Association of MAGE A3 with Aggressive Features in Thyroid Tumors MB Martins, MA Marcello, FA Batista, LL Cunha, EC Morari, FA Soares, ... Journal of immunology research 2014, 2014 | 7 | 2014 |
| Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum FA Batista, SS Bosch, S Butzloff, S Lunev, KA Meissner, M Linzke, ... MicrobiologyOpen 8 (7), e00779, 2019 | 6 | 2019 |
| 3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor M Martinez, FA Batista, M Maurel, A Bouillon, L Ortega Varga, ... Acta Crystallographica Section D: Structural Biology 79 (8), 2023 | 2 | 2023 |
| Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian … MB Martins, F de Assis Batista, NE Bufalo, KC Peres, M Meneghetti, ... Endocrine 72 (2), 470-478, 2021 | 2 | 2021 |
| Polymorphisms in IL-2 and IL-6R increase serum levels of the respective interleukins in differentiated thyroid cancer MB Martins, MA Marcello, F de Assis Batista, KC Peres, M Meneghetti, ... Meta Gene 23, 100621, 2020 | 2 | 2020 |
| Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions MB Martins, F de Assis Batista, MA Marcello, NE Bufalo, KC Peres, ... Annals of Diagnostic Pathology 53, 151766, 2021 | 1 | 2021 |
